These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 2175806)
1. MDL 27,032 [4-propyl-5-(4-pyridinyl)-2(3H)-oxazolone], an active site-directed inhibitor of protein kinase C and cyclic AMP-dependent protein kinase that relaxes vascular smooth muscle. Robinson PJ; Cheng HC; Black CK; Schmidt CJ; Kariya T; Jones WD; Dage RC J Pharmacol Exp Ther; 1990 Dec; 255(3):1392-8. PubMed ID: 2175806 [TBL] [Abstract][Full Text] [Related]
2. Relaxation of vascular smooth muscle by HA-1004, an inhibitor of cyclic nucleotide-dependent protein kinase. Ishikawa T; Inagaki M; Watanabe M; Hidaka H J Pharmacol Exp Ther; 1985 Nov; 235(2):495-9. PubMed ID: 2997436 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of experimental metastasis and cell adhesion of B16F1 melanoma cells by inhibitors of protein kinase C. Dumont JA; Jones WD; Bitonti AJ Cancer Res; 1992 Mar; 52(5):1195-200. PubMed ID: 1737379 [TBL] [Abstract][Full Text] [Related]
4. Regulation of contractile activity in vascular smooth muscle by protein kinases. Silver PJ Rev Clin Basic Pharm; 1985; 5(3-4):341-95. PubMed ID: 3029813 [TBL] [Abstract][Full Text] [Related]
5. MDL 27,032 relaxes vascular smooth muscle and inhibits protein kinase C. Cheng HC; Robinson PJ; Dage RC; Jones WD J Cardiovasc Pharmacol; 1991 Mar; 17(3):445-55. PubMed ID: 1711607 [TBL] [Abstract][Full Text] [Related]
6. The actions of prostaglandin E2 on potassium currents in rat tail artery vascular smooth muscle cells: regulation by protein kinase A and protein kinase C. Ren J; Karpinski E; Benishin CG J Pharmacol Exp Ther; 1996 Apr; 277(1):394-402. PubMed ID: 8613946 [TBL] [Abstract][Full Text] [Related]
7. Protein kinase C modulates effects of prostanoids on cyclic adenosine monophosphate in guinea pig chief cells. Raufman JP; Cosowsky L J Cell Physiol; 1989 Jul; 140(1):91-7. PubMed ID: 2544618 [TBL] [Abstract][Full Text] [Related]
8. PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries. Santos-Silva AJ; Cairrão E; Morgado M; Alvarez E; Verde I Eur J Pharmacol; 2008 Mar; 582(1-3):102-9. PubMed ID: 18234184 [TBL] [Abstract][Full Text] [Related]
9. KT5926, a potent and selective inhibitor of myosin light chain kinase. Nakanishi S; Yamada K; Iwahashi K; Kuroda K; Kase H Mol Pharmacol; 1990 Apr; 37(4):482-8. PubMed ID: 2325635 [TBL] [Abstract][Full Text] [Related]
10. Effect of the kinase inhibitor, H-7, on stress, crossbridge phosphorylation, muscle shortening and inositol phosphate production in rabbit arteries. Ratz PH J Pharmacol Exp Ther; 1990 Jan; 252(1):253-9. PubMed ID: 2299593 [TBL] [Abstract][Full Text] [Related]
11. Protein kinase C inhibits the Ca(2+)-activated K+ channel of cultured porcine coronary artery smooth muscle cells. Minami K; Fukuzawa K; Nakaya Y Biochem Biophys Res Commun; 1993 Jan; 190(1):263-9. PubMed ID: 8422251 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of the low Km cyclic AMP phosphodiesterase and activation of the cyclic AMP system in vascular smooth muscle by milrinone. Silver PJ; Lepore RE; O'Connor B; Lemp BM; Hamel LT; Bentley RG; Harris AL J Pharmacol Exp Ther; 1988 Oct; 247(1):34-42. PubMed ID: 2845058 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of human natural killer cell activity by the protein kinase C inhibitor 1-(5-isoquinolinesulfonyl)-2-methylpiperazine is an early but post-binding event. Steele TA; Brahmi Z J Immunol; 1988 Nov; 141(9):3164-9. PubMed ID: 3262683 [TBL] [Abstract][Full Text] [Related]
14. Activation of protein kinase C by myristate and its requirements of Ca2+ and phospholipid. Iwata M; Edashige K; Saeki K Physiol Chem Phys Med NMR; 1990; 22(4):211-8. PubMed ID: 2101933 [TBL] [Abstract][Full Text] [Related]
15. The role of myosin light chain kinase phosphorylation in beta-adrenergic relaxation of tracheal smooth muscle. Miller JR; Silver PJ; Stull JT Mol Pharmacol; 1983 Sep; 24(2):235-42. PubMed ID: 6136904 [TBL] [Abstract][Full Text] [Related]
16. Staurosporine, a novel protein kinase inhibitor, enhances HL-60-cell differentiation induced by various compounds. Okazaki T; Kato Y; Mochizuki T; Tashima M; Sawada H; Uchino H Exp Hematol; 1988 Jan; 16(1):42-8. PubMed ID: 2826200 [TBL] [Abstract][Full Text] [Related]
17. Effect of H-7 on the modulation of glucagon actions by activators of protein kinase-C. García-Sáinz JA; Hernández-Sotomayor SM; Contreras-Rodríguez JL; Macías-Silva M Biochem Int; 1989 Jan; 18(1):243-9. PubMed ID: 2719714 [TBL] [Abstract][Full Text] [Related]
18. Evidence for involvement of the protein kinase C pathway in the activation of p37v-mos protein kinase. al-Bagdadi F; Singh B; Arlinghaus RB Oncogene; 1990 Aug; 5(8):1251-7. PubMed ID: 2168030 [TBL] [Abstract][Full Text] [Related]
19. A calcium-dependent protein kinase is present in tetrahymena. Hegyesi H; Csaba G Cell Biochem Funct; 1994 Sep; 12(3):221-6. PubMed ID: 7955132 [TBL] [Abstract][Full Text] [Related]
20. Signal transduction in avian granulosa cells: effects of protein kinase C inhibitors. Jamaluddin M; Molnár M; Marrone BL; Hertelendy F Gen Comp Endocrinol; 1994 Mar; 93(3):471-9. PubMed ID: 8194746 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]